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On April 25, 2009, Singapore implemented strict con-
tainment measures for pandemic (H1N1) 2009 with en-
hanced surveillance and hospital isolation. In the ﬁ  rst month, 
seasonal inﬂ  uenza, predominantly virus subtype H3N2, was 
diagnosed for 32% of patients with acute febrile respiratory 
illness. Our ﬁ  ndings underscore the high prevalence of sea-
sonal inﬂ  uenza in Singapore.
T
ropical countries experience inﬂ   uenza year round, 
with 2 peaks corresponding to the rainy seasons (1). 
Despite this year-round activity, seasonal inﬂ  uenza is of-
ten neglected in tropical countries in terms of clinical di-
agnosis, treatment, and vaccination (2). In Singapore, in-
ﬂ  uenza activity usually peaks in June and December (3). 
The annual all-cause death rate from seasonal inﬂ  uenza 
in Singapore has been estimated at 14.8/100,000 person-
years; the proportion of deaths among persons ≥65 years 
of age is 11.3× higher than that among the general popula-
tion (4). In addition, previous pandemic inﬂ  uenza–related 
excess deaths in Singapore are comparable to those in 
temperate countries (5). 
In April 2009, a novel inﬂ  uenza A virus (H1N1) of 
swine origin emerged in the United States (6) and triggered 
alarm about its pandemic potential (7). On June 11, 2009, 
the World Health Organization announced that the virus 
had become pandemic; it is now referred to as pandemic 
(H1N1) 2009 virus (8). We report on enhanced inﬂ  uenza 
surveillance in Singapore that was implemented before the 
ﬁ  rst case of pandemic (H1N1) 2009 was detected on May 
26, 2009, and we describe the transition in Singapore from 
inﬂ  uenza cases caused predominantly by seasonal inﬂ  uen-
za to cases caused exclusively by pandemic (H1N1) 2009 
virus.
The Study
This surveillance study was approved by the Chairman 
of Medical Board, Tan Tock Seng Hospital (TTSH), Sin-
gapore. The clinical study was approved by the Domain 
Speciﬁ  c Review Board, National Healthcare Group, Sin-
gapore.
On April 25, 2009, Singapore’s Ministry of Health 
initiated containment measures in response to pandemic 
(H1N1) 2009. Travelers returning from affected countries 
to Singapore with acute febrile respiratory illness were 
screened at the TTSH emergency department, the desig-
nated screening center for pandemic (H1N1) 2009. Ther-
mal screening was conducted at all border entry points, and 
the mass media publicized nationwide that persons with a 
risk for pandemic (H1N1) 2009 virus infection based on 
travel history, fever, and respiratory symptoms should go 
to the TTSH emergency department for screening. Com-
bined nasal and throat swab specimens were tested with an 
in-house, gel-based PCR for inﬂ  uenza A, H1, H3, H5, N1, 
and N2. All specimens with subtype H1N1–positive test 
results underwent in-house, probe-based inﬂ  uenza (H1N1) 
2009 PCR, and partial sequencing of the matrix gene was 
conducted to conﬁ  rm positive PCR results.
From April 27 through May 24, 2009, a total of 300 per-
sons (244 travelers returning from affected countries with 
a respiratory illness and 56 symptomatic contacts) were 
screened for inﬂ  uenza infection: 24.0% had subtype H3N2, 
1.6% had seasonal subtype H1N1, and 2.7% had inﬂ  uenza 
B. The median age of patients was 36 years (range 10–70 
years), and 14.7% had other illnesses (asthma [52.3% of 
those with other illnesses], diabetes mellitus [29.5%], heart 
disease [11.4%], cancer [4.5%], and HIV [4.5%]). Fever 
was reported for 92.9% of all screened persons, cough for 
82.4%, sore throat for 57.6%, rhinorrhea for 62.4%, my-
algia for 25.9%, headache for 16.5%, and gastrointestinal 
symptoms for 9.4%.
Two thirds of the patients with inﬂ  uenza-positive PCR 
results met the criteria for inﬂ  uenza-like illness (ILI) as de-
ﬁ  ned by the US Centers for Disease Control and Prevention 
(CDC) (9). Patients who met these criteria were more likely 
than those who did not to have inﬂ  uenza-positive PCR re-
sults (odds ratio [OR] 8.1, 95% conﬁ  dence interval [CI] 
4.6–14.3, p = 0.0001). Compared with contacts who had no 
recent travel, travelers returning from North America were 
less likely to have inﬂ  uenza-positive PCR test results (OR 
0.13, 95% CI 0.06–0.27, p = 0.0001).
To enhance detection of pandemic (H1N1) 2009, we 
obtained nasal and throat swab samples on May 2 and 3, 
2009, from all hospitalized patients with clinically sus-
pected pneumonia, regardless of their travel history. The 
samples were tested by PCR for inﬂ  uenza. A total of 146 
patients were screened, of whom 21 (14.4%) were positive 
for inﬂ  uenza; 10.3% of the 146 patients had H3N2, 1.4% 
had seasonal H1N1, and 2.7% had inﬂ  uenza B. The median 
age of these patients was 67 years (range 20–95 years), and 
their median hospital stay at screening was 1 day (range 
0–17 days). Of the patients, 52% were male, and 86% had 
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had a fever, 76% had a cough, 24% had a sore throat, 52% 
had rhinorrhea, 24% had myalgia, and 19% had headache. 
Findings on chest radiographs were abnormal for 10 pa-
tients (48%), of whom 5 had ﬁ  ndings consistent with pneu-
monia. All but 1 patient were treated with antimicrobial 
drugs; none was given antiviral drug therapy. The median 
hospital stay was 5 days (range 1–38 days). Two patients 
died; both had multiple illnesses.
In addition, during May 2–8, 2009, as part of nation-
wide enhanced inﬂ   uenza surveillance, nasal and throat 
swab specimens from patients screened at the TTSH emer-
gency department were tested by PCR for inﬂ  uenza virus. 
The patients had fever or respiratory symptoms but no his-
tory of travel to an affected country. Overall, 95 patients 
were screened, of whom 30 (31.6%) had positive results 
for inﬂ  uenza; 24.2% of the 95 patients had H3N2 and 7.4% 
had inﬂ  uenza B. Fever was reported for 69.5% of the 95 pa-
tients, cough for 75.8%, sore throat for 56.8%, rhinorrhea 
for 58.9%, myalgia for 16.8%, and headache for 44.2%. 
Of the 30 patients with PCR results positive for inﬂ  uenza, 
22 (73%) met the criteria for ILI. Compared with patients 
who did not meet these criteria, patients who did meet them 
were 3× more likely to have inﬂ  uenza-positive PCR results 
(OR 3.02, 95% CI 1.17–7.75, p = 0.019). Only 6 (6.3%) of 
the 95 patients had self-reported inﬂ  uenza vaccination in 
the preceding 6 months.
Screening of patients with ILI symptoms continued at 
the TTSH emergency department, and from May 3 through 
June 13, 2009, only seasonal inﬂ  uenza (predominantly vi-
rus subtype H3N2) was detected. Pandemic (H1N1) 2009 
was ﬁ  rst detected during the week beginning June 14, and 
the weekly incidence rapidly increased until the week end-
ing July 25, when all inﬂ  uenza cases were caused by pan-
demic (H1N1) 2009 virus (Figure).
By July 25, 2009, a total of 838 patients with pan-
demic (H1N1) 2009 virus infection had been seen at the 
TTSH emergency department. The median age of patients 
was 22 years (range 10–90 years). Fever was reported for 
85.3%, cough for 87.2%, sore throat for 55.4%, rhinorrhea 
for 41.6%, myalgia for 11.1%, and headache for 11.0%; 
57% of patients met the CDC criteria for ILI. Patients with 
pandemic (H1N1) 2009 were signiﬁ  cantly younger (p = 
0.0001) than patients with seasonal inﬂ  uenza, but the pro-
portion with ILI in each group was similar (OR 0.65, 95% 
CI 0.41–1.04, p = 0.071).
Conclusions
Each year in the United States, seasonal inﬂ  uenza ac-
counts for >200,000 hospitalizations and 41,000 deaths, 
and it is the seventh leading cause of death (10). The effect 
of seasonal inﬂ  uenza in the tropics is less well studied. In 
Thailand, inﬂ  uenza was detected in 11%–12.5% of patients 
with community-acquired pneumonia and in 23% of outpa-
tients with ILI (11,12).
Enhanced inﬂ  uenza surveillance in Singapore in re-
sponse to pandemic (H1N1) 2009 yielded a high prevalence 
of seasonal inﬂ  uenza: 28.3% (85 of 300) among returning 
travelers and their contacts with respiratory symptoms, 
14.4% (21 of 146) among hospitalized patients with sus-
pected pneumonia, and 31.6% (30 of 95) among patients 
self-reporting to the TTSH emergency department with 
fever and respiratory symptoms but without a history of 
travel to affected countries. These ﬁ  ndings reﬂ  ect the peak 
local inﬂ  uenza season (2,4–5). The risk of having seasonal 
inﬂ  uenza was lower among travelers returning from North 
America, a ﬁ  nding that was consistent with the timing of 
the peak local inﬂ  uenza season and the noninﬂ  uenza season 
in the Northern Hemisphere.
Of 21 patients with inﬂ  uenza-positive PCR results, 
only 5 had radiographic evidence of pneumonia despite 
having a pneumonia diagnosis based on an acute history of 
fever and cough. No patients, including those with positive 
test results, were treated with antiviral drugs. This ﬁ  nding, 
in addition to low inﬂ  uenza vaccine coverage in Singapore, 
reﬂ  ects the underappreciation of inﬂ  uenza by doctors in 
this country.
Of note, 67%–73% of the patients with inﬂ  uenza-
positive PCR results met the CDC ILI criteria during the 
study period; this ﬁ  nding may guide testing for seasonal 
inﬂ  uenza during peak inﬂ  uenza seasons in May–June and 
December. Its value in nonpeak seasons, however, requires 
further evaluation because inﬂ  uenza occurs year-round in 
the tropics (1). Temperature >38°C and either cough or 
sore throat (13) were the most speciﬁ  c screening criteria 
and had the best positive predictive value; temperature of 
37.5°C and either cough, sore throat, or rhinorrhea were the 
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Figure. Inﬂ   uenza-positive test results for surveillance samples 
obtained at the emergency department, Tan Tock Seng Hospital, 
Singapore, May 3–July 25, 2009. An epidemiologic week starts on 
a Sunday and ends on a Saturday (e.g., week 18 started on May 3 
and week 29 on July 19). *Undetermined inﬂ  uenza A subtypes.Pandemic and Seasonal Inﬂ  uenza, Singapore
most sensitive screening criteria and had the best negative 
predictive value for inﬂ  uenza (Table).
Our ﬁ  ndings highlight a high prevalence of seasonal 
inﬂ  uenza during peak times in Singapore; the prevalence 
is comparable to that during typical inﬂ  uenza seasons in 
temperate countries in the Southern Hemisphere. This 
prevalence underscores the need for not neglecting sea-
sonal inﬂ  uenza and for a more robust surveillance system 
to be in place for community and hospital monitoring in 
Singapore.
Dr Leo is clinical director of the Communicable Disease 
Centre, Tan Tock Seng Hospital, Singapore. Her research inter-
ests include HIV, dengue, inﬂ  uenza, and other emerging infec-
tious diseases.
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Temperature >37.5°C and cough or sore throat  74.1 71.6 50.8 87.5
Temperature >37.5°C and cough, sore throat, or rhinorrhea  81.2 71.2 52.7 90.5
Temperature >37.8°C and cough or sore throat (9) 67.1 80.0 57.0 86.0
Temperature >38°C and cough or sore throat (13) 54.1 87.0 62.2 82.7